Sigilon Therapeutics, Inc. (SGTX)

Not featured in screeners

Not featured in screeners

Ticker: SGTX Exchange: NSM

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

ELI LILLY & Co

1 purchase — total 25,639,916 USD

Buy 11 Aug 2023

Value US$3,904,546.17 | Price 293.20 | Shares 88,597

ANDERSON DANIEL GRIFFITH

1 sale — total 2,000,000 USD

Sale 2 Jun 2021

Value US$3,642,443.95 | Price 61.04 | Shares 5,672

ELI LILLY & Co

1 purchase — total 5,400,000 USD

Buy 8 Dec 2020

Value US$5,400,000.00 | Price 18.00 | Shares 300,000

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2023-08-14	2023-08-11	B Purchase	1.5 ELI LILLY & Co Large shareholder	88,597 +49.2% 293.20 US$3,904,546	88,597 +49.2%	293.20	US$3,904,546
2021-06-04	2021-06-02	S Sale	ANDERSON DANIEL GRIFFITH Non-Executive Director	5,672 +27.0% 61.04 US$3,642,444	5,672 +27.0%	61.04	US$3,642,444
2020-12-10	2020-12-08	B Purchase	1.5 ELI LILLY & Co Large shareholder	34,828 +27.7% 150.21 US$836,688	34,828 +27.7%	150.21	US$836,688

More insider trading research around Sigilon Therapeutics, Inc.